Home >> Life Sciences >> Healthcare

Globoid Cell Leukodystrophy (Krabbe Disease) - Pipeline Review, H1 2017

Published: Jun-2017 | Format: PDF | Global Markets Direct | Number of pages: 40 | Code: MRS - 139818

Globoid Cell Leukodystrophy (Krabbe Disease) - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Globoid Cell Leukodystrophy (Krabbe Disease) - Pipeline Review, H1 2017, provides an overview of the Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) pipeline landscape.

Krabbe disease also called globoid cell leukodystrophy is a degenerative disorder caused by the deficiency of an enzyme called galactosylceramidase. This enzyme deficiency impairs the growth and maintenance of myelin. Symptoms include seizures, Muscle spasms, Loss of head control, vomiting, fevers, irritability and excessive crying. Risk factors include family history. Treatment focuses on managing symptoms (anticonvulsant, muscle relaxer) and providing supportive care.  

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Globoid Cell Leukodystrophy (Krabbe Disease) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Globoid Cell Leukodystrophy (Krabbe Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Preclinical and Discovery stages are 3 and 1 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 1 molecules, respectively.

Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 
- The pipeline guide reviews latest news related to pipeline therapeutics for Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Globoid Cell Leukodystrophy (Krabbe Disease) - Overview
Globoid Cell Leukodystrophy (Krabbe Disease) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Globoid Cell Leukodystrophy (Krabbe Disease) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Globoid Cell Leukodystrophy (Krabbe Disease) - Companies Involved in Therapeutics Development
Commence Bio Inc
Kyorin Pharmaceutical Co Ltd
Globoid Cell Leukodystrophy (Krabbe Disease) - Drug Profiles
CMB-200 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DUOC-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ibudilast - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MGTA-456 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RND-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Stem Cell Therapy for Globoid Cell Leukodystrophy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Globoid Cell Leukodystrophy (Krabbe Disease) - Dormant Projects
Globoid Cell Leukodystrophy (Krabbe Disease) - Discontinued Products
Globoid Cell Leukodystrophy (Krabbe Disease) - Product Development Milestones
Featured News & Press Releases
Jan 18, 2016: FDA Grants Rare Pediatric Disease Designation to MediciNova’s MN-166 (ibudilast) for the Treatment of Krabbe Disease
Jun 03, 2015: MediciNova Announces FDA Granted Orphan Drug Designation to MN-166 (ibudilast) for Krabbe Disease
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

United States HbA1c Testing Device Market by Manufacturers, States, Type and Application, Forecast to 2022

Feb-2018 | Global Info Research | Pages : 116 | Code : MRS-215980 | 4480

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes. Scope of the Report: This report focuses on the HbA1c Testing Device in United States market, to split the market based on manufacturers, states, type and application. Market Segment by Manufacturers, this report covers Abbott Laboratories Roche Siemens Tosoh Danaher Corporation Read more

United States Embolization Particle Market by Manufacturers, States, Type and Application, Forecast to 2022

Feb-2018 | Global Info Research | Pages : 118 | Code : MRS-215979 | 4480

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells. Scope of the Report: This report focuses on the Embolization Particle in United States market, to split the marke Read more

United States Disposable Ostomy Bags Market by Manufacturers, States, Type and Application, Forecast to 2022

Feb-2018 | Global Info Research | Pages : 117 | Code : MRS-215978 | 4480

Disposable?Ostomy?Bags is a?prosthetic?medical device?that provides a means for the collection of waste from a surgically diverted biological system (colon,?ileum,?bladder) and the creation of a?stoma. Pouching systems are most commonly associated with?colostomies,?ileostomies, and urostomies. Scope of the Report: This report focuses on the Disposable Ostomy Bags in United States market, to split the market based on manufacturers, states, type and application. Market Segment by Man Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Epileptic Seizure Monitor Alarm System Market 2018 Forecast to 2023

Feb-2018 | Global Info Research | Pages : 108 | Code : MRS-215977 | 4880

Epileptic Seizure Monitor Alarm System is a seizure-detection system that can be used long-term and in home situations for early intervention and prevention of seizure related side effects including SUDEP (sudden unexpected death in epileptic patients). Scope of the Report: This report focuses on the Epileptic Seizure Monitor Alarm System in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market base Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Artificial Pancreas Devices Systems Market 2018 Forecast to 2023

Feb-2018 | Global Info Research | Pages : 104 | Code : MRS-215976 | 4880

"The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas. Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM." Scope of the Report: This report focuses on the Artificial Pancreas Devices Read more

Global Herb Oil Industry Situation and Prospects Market Research report 2017 - 2022

Jan-2018 | Stanley | Pages : 138 | Code : MRS-215427 | 2850

Summary The Global Herb Oil Industry Situation and Prospects Research report is a professional and in-depth study on the current state of the Herb Oil industry. In 2016, the world economy expanded by just 2.2 per cent, the slowest rate of growth since the Great Recession of 2009. Underpinning the sluggish global economy are the feeble pace of global investment, dwindling world trade growth, flagging productivity growth and high levels of debt. World gross product is forecast to expand Read more

Global Digestive System Drug Industry Situation and Prospects Market Research report 2017 - 2022

Jan-2018 | Stanley | Pages : 158 | Code : MRS-215426 | 2850

Summary The Global Digestive System Drug Industry Situation and Prospects Research report is a professional and in-depth study on the current state of the Digestive System Drug industry. In 2016, the world economy expanded by just 2.2 per cent, the slowest rate of growth since the Great Recession of 2009. Underpinning the sluggish global economy are the feeble pace of global investment, dwindling world trade growth, flagging productivity growth and high levels of debt. World gross pro Read more

North America and Europe Venous Stents Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 103 | Code : MRS-215075 | 4480

This report studies the Venous Stents market. Venous stents are metal mesh tubes that expand against blocked or narrowed vein walls. They act as a scaffold to keep veins open. In most cases, surgeons place venous stents in larger, central veins, such as those found in the legs, chest and abdomen. Scope of the Report: This report focuses on the Venous Stents in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This rep Read more

North America and Europe Tyrosine Kinase JAK Inhibitors Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 101 | Code : MRS-215074 | 4480

Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway. Scope of the Report: This report focuses on the Tyrosine Kinase JAK Inhibitors in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categor Read more

North America and Europe Acinetobacter Infections Treatment Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 101 | Code : MRS-215073 | 4480

Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections. Scope of the Report: This report focuses on the Acinetobacter Infections Treatment in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufactu Read more

  • Payment Mode
Single User | $(USD)2000 View Pricing